PFF preparation tail (storage / sonication / pilot validation), Vargas 2019 Summary of a-syn animal models Table 1, Transgenic vs Vector vs Injection matrix, MOA of aSyn spreading axon transport table, Antibodies to aSyn start

PFF preparation (continued)

PFF storage / generation:

37°C with shaking for 7 days, and subjected to a quality test. α-Syn PFFs should not be stored at 4°C or -20°C because dissociation might occur. They should only be stored at -80°C.33 It is advisable to use freshly prepared PFFs. Samples stored in the shortterm at room temperature or at -80°C for up to 1.5 years retain pathogenicity but can lose activity.34 To generate pathogenic species of PFFs, the fibrils should be diluted and sonicated immediately before use. To achieve consistent pathogenicity, sonication must produce short fibrils with a length of 50 nm or shorter as the pathogenicity of α-syn PFFs depends on the structure and size of the fibrils.35,36 Other than regular quality control experiments used to validate the conversion of monomeric α-syn to PFFs, in vivo pilot studies are required to validate the pathogenicity of PFF species before any long-term in vivo studies. All parameters at every step in the standard protocol should be validated and tailored to each study’s purposes and models.34

Summary of a-syn animal models (J.Y. Vargas et al., Ageing Research Reviews 50 (2019) 89-101)

Table 1 — Summary of in vivo studies representing the major milestones in the understanding of α-syn prion-like spreading properties.

Experimental approachAnimalsMaterial assayedRegion of interestTime pointsReferences
Engrafted neurons on PD brainsThy-1 α-syn transgenic miceMouse cortical neuronal stem cellsHippocampus4 weeksDesplats et al., 2009
Rats (WT) injected with AAV-α-synRat embryonic ventral mesencephalic neuronsStriatum1 week 2 weeks 4 weeksAngot et al., 2012
Intracerebral inoculation/expression of α-synC57BL6/C3H mice (WT)Mouse α-syn fibrilsStriatum30 days 90 days 180 daysLuk et al., 2012a
C57BL/6J mice (WT)Human α-syn monomers and fibrilsOlfactory bulb1 week, 3 h, 12 h, 72 hRey et al., 2013
WT and α-syn null mice, monkeysα-Syn extracts from the PD patientsSubstantia nigra and striatum4 weeks 16 weeks 56-68 weeksRecasens et al., 2014
Rats (WT)Human α-syn oligomers, fibrils and ribbons. AAV-α-synSubstantia nigra7 days 120 daysPeelaerts et al., 2015
Peripheric administration of α-synWT and α-syn null miceAAV-GFP AAV-α-synVagus nerve2 weeks 6 weeks 12 weeksHelwig et al., 2016
WT and α-syn transgenic miceα-Syn fibrilsSciatic nerve14 weeksAyers et al., 2014b
WT and α-syn transgenic miceGut microbiota from PD donors12-13 weeks and 24-25 weeksSampson et al., 2016

Transgenic vs Vector-mediated α-syn vs Injection comparison

NHP available?a-syn expression levela-syn accumulation/aggregationa-syn propagationNeurodegenerationBehavior
TransgenicXToo much than humanoXX (alpha-synuclein cell loss has been reported in only 2 of the many mouse models over-expressing alpha-syn: a line expressing a doubly mutated protein, which is not found in patients, and in a line expressing a truncated alpha-syn [36, 37]; ↓ 50% reduction in TH-positive neurons, 24-weeks post-AAV injection)X
Vector-mediated α-syn (vector-mediated α-syn overexpression)OToo much than humanO (inclusions develop)X
InjectionoLess than AAVooo

MOA of aSyn spreading

Retrograde axonal spread (transport) 보인다는 것 같음 (동물모델에서 sciatic nerve 까지 가는 듯).

de axons (showing direction)Secreted into extracellular spaceIn ECFUptakeRecipient cellPathological aggregationLewy bodiesTotal a-synSecondary secretion
retrograde AT (Brundt 2012)Exosomepassive way (diffusion)건강함 (Both fibrillar form of αSyn and non-fibrillar oligomeric αSyn and aggregated αSyn (in lysosome with a half life of 7 h in SH-SY5Y cells & RAT embryonic cortical neuron) [10] (Lee 2008 #620), monomeric αSyn 도 있지만 endogenous monomers αSyn 일컬 (Bae 2014 #610))Co-aggregation with resident αSyn, can recruit other soluble monomers that assemble to form aggregates9fiber but not like LB rounded
antero & retro AT (Brahic 2016)exophagyactive way (endocytosis)α-syn associates to lipid rafts, and more specifically to the glycolipid ganglioside GM1, which is abundantly expressed in the brain (Fortin et al., 2004; Olive et al., 1995).
(Bae, 2014 #610) Aggregated aSyn 만 exocytosis 된다 b/c 이런 놈만 세포막에 구멍냄 ((Vasili, 2019 #616).extracellular proteases, such as MMP3, directly cleaves secreted a-syn monomers
Extracellular aSyn Activates microglia → kills DA neurons (Lee, 2008 #620)

Antibodies to aSyn (start)

Pathologic conversionPathological aggregation
monomerictetramerPhosphorylated a-synMisfolded monomerB-pleated sheetInsolubleOligomeric (still soluble)protofibrilinsoluble amyloid-like fibrilLewy bodiesTotal a-syn
(antibody)(20200414) ADx Neurosciences, TV Q3 FY2020, CS : Q42020,
• 기존 : anti-pS129 a-syn antibody
(Waxman, 2008 #535) Syn505, Syn506 and Syn514 recognize conformational variants of α-synThioflavin-staining (antibody는 아니지만)(20200414) ADx Neurosciences, TV Q4 FY2020, CS : Q3 FY2021,mouse anti-a-syn fibrils [02; [43]]